v3.26.3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]            
Research and development expense (includes related party amounts $ 975 $ 0 $ 975 $ 0 $ 300 $ 2,150
Net income (loss) per common share, basic $ 0.27 $ (15.99) $ (3.73) $ (29.16) $ (50.66) $ (71.83)
Net income (loss) per common share, diluted $ 0.27 $ (15.99) $ (3.73) $ (29.16) $ (50.66) $ (71.83)
Weighted-average shares of common stock outstanding, basic 1,660,586 1,170,087 1,581,554 1,167,550 1,176,558 971,467
Weighted-average shares of common stock outstanding, diluted 1,661,709 1,170,087 1,581,554 1,167,550 1,176,558 971,467